Ambu A/S (OTCMKTS:AMBBY) Releases Earnings Results

Ambu A/S (OTCMKTS:AMBBY) announced its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Stock Up 12.4%

Ambu A/S stock traded up $1.50 during midday trading on Thursday, hitting $13.60. 1,000 shares of the company’s stock were exchanged, compared to its average volume of 45. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.69 and a current ratio of 2.77. The company has a market cap of $3.20 billion, a PE ratio of 44.00 and a beta of 0.86. The firm has a 50-day moving average of $11.10 and a two-hundred day moving average of $10.99. Ambu A/S has a 12 month low of $8.54 and a 12 month high of $14.18.

Analyst Upgrades and Downgrades

Separately, UBS Group downgraded Ambu A/S from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 15th. One research analyst has rated the stock with a Hold rating. Based on data from MarketBeat, Ambu A/S has an average rating of “Hold”.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.